Mild to Moderate Atopic Dermatitis Clinical Trial
Official title:
Randomized, Double Blind, Clinical Study for Evaluating the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic Dermatitis. Controlled Study vs Placebo
Evaluation of safety and clinical efficacy of an active ingredient versus placebo for the treatment of mild to moderate Atopic Dermatitis (AD) adults.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03250663 -
Eucrisa for Atopic Dermatitis
|
Phase 1 | |
| Not yet recruiting |
NCT06052995 -
Observational Study to Evaluate Use of Elidel® in South and East Asian Pediatric Patients With Atopic Dermatitis.
|
||
| Terminated |
NCT00996008 -
CT 327 in the Treatment of Atopic Dermatitis
|
Phase 2 | |
| Completed |
NCT01568489 -
Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
|
Phase 2 | |
| Completed |
NCT01079897 -
Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic Dermatitis
|
N/A | |
| Completed |
NCT02079688 -
Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema
|
Phase 2 | |
| Not yet recruiting |
NCT05729074 -
A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients
|
Phase 1 | |
| Completed |
NCT00568412 -
A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis
|
Phase 4 |